filmov
tv
Spotlight on FDA’s process to approving Pfizer’s vaccine

Показать описание
Dr. Peter Laurie, president of the Center for Science in the Public Interest, breaks down the FDA’s COVID-19 vaccine approval process.
In the Spotlight: Recent FDA Updates and Guidance for Rare Disease Drug Development
INVESTIGATION UPDATE | Broken Birth Control
2021 FDA Science Forum: Main Session and Keynote
About FDA’s Regulatory Science Program
A Look at Rare Disease Listening Sessions with NORD and the FDA
How to Prepare for, Manage, and Follow-up to an FDA Inspection - GlobalCompliancePanel
Expedited Approvals, the Regulatory Impacts, and FDA’s Long Term Strategy
Michael Nguyen, M.D.
FDA Orphan Drugs Program and Financial Incentives for CDER Medical Products- June 10, 2019
New spotlight on J&J COVID-19 vaccine
Registration & Results Reporting of FDA-Regulated Medical Products
Complying with the FDA’s Rule on LDTs – What you need to Do and When
Regulatory Compliance Consulting Services
How the Pfizer COVID-19 vaccine was approved so quickly
First Launch And Commercialisation 2011-2020 – Spotlight On Rare Diseases And Oncology
Part 1: Rare Disease Clinical Research – Spotlight on the Patient and Caregiver
J&J booster shots, mixing and matching vaccines in spotlight Friday
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 2 – Part 2
10 Dr. Maricel Maffini, independent consultant, USA
Zach Harned - FDA, AI/ML, and Medical Devices
Synthetic Therapeutic Peptide APIs: Documentation for API Sameness & Related Impurities
Complex Product Characterization/Analysis - Session 2A
Does the FDA approve your supplements?
Are Your Food Labels FDA Compliant?
Комментарии